[HTML][HTML] A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA
The mechanism by which p38 mitogen-activated protein kinase (MAPK) regulates the
induction of cyclooxygenase (COX)-2 by interleukin-1 (IL-1) has been investigated in HeLa
cells. SB 203580, an inhibitor of p38 MAPK, in the range 0.1–1 μM inhibited IL-1-stimulated
PGE2 (but not arachidonic acid) release and this was associated with inhibition of induction
of COX-2 protein and mRNA. IL-1 stimulated COX-2 transcription in HeLa cells about 2-fold
as judged by both reporter gene and nuclear run-on assays. The inhibitor had no significant …
induction of cyclooxygenase (COX)-2 by interleukin-1 (IL-1) has been investigated in HeLa
cells. SB 203580, an inhibitor of p38 MAPK, in the range 0.1–1 μM inhibited IL-1-stimulated
PGE2 (but not arachidonic acid) release and this was associated with inhibition of induction
of COX-2 protein and mRNA. IL-1 stimulated COX-2 transcription in HeLa cells about 2-fold
as judged by both reporter gene and nuclear run-on assays. The inhibitor had no significant …
The mechanism by which p38 mitogen-activated protein kinase (MAPK) regulates the induction of cyclooxygenase (COX)-2 by interleukin-1 (IL-1) has been investigated in HeLa cells. SB 203580, an inhibitor of p38 MAPK, in the range 0.1–1 μM inhibited IL-1-stimulated PGE2 (but not arachidonic acid) release and this was associated with inhibition of induction of COX-2 protein and mRNA. IL-1 stimulated COX-2 transcription in HeLa cells about 2-fold as judged by both reporter gene and nuclear run-on assays. The inhibitor had no significant effect on this. However, in cells previously stimulated with IL-1 it caused rapid destabilisation of COX-2 mRNA independently of on-going transcription. The results suggest a novel function for p38 MAPK in the regulation of mRNA stability.
Elsevier